Gene · 4841
Papers2,010
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,010
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling Pathways of the Insulin-like Growth Factor Binding Proteins. | Endocr Rev | 2023 | 36974712 | PubTator, text mining | PubMed |
| Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | BMC Genomics | 2023 | 36964488 | PubTator, text mining | PubMed |
| An Evaluation on the Role of Non-Coding RNA in HIV Transcription and Latency: A Review. | HIV AIDS (Auckl) | 2023 | 36942082 | PubTator, text mining | PubMed |
| Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions. | Chem Sci | 2023 | 36937574 | PubTator, text mining | PubMed |
| PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer. | Mol Cell Proteomics | 2023 | 36931626 | PubTator, text mining | PubMed |
| Identification of patient subtypes based on protein expression for prediction of heart failure after myocardial infarction. | iScience | 2023 | 36915695 | PubTator, text mining | PubMed |
| Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding. | Front Cell Dev Biol | 2023 | 36910146 | PubTator, text mining | PubMed |
| Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies. | Cells | 2023 | 36899868 | PubTator, text mining | PubMed |
| Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL. | Oncoimmunology | 2023 | 36875548 | PubTator, text mining | PubMed |
| Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 36875159 | PubTator, text mining | PubMed |
| Whole blood transcriptome analysis in dairy calves experimentally challenged with bovine herpesvirus 1 (BoHV-1) and comparison to a bovine respiratory syncytial virus (BRSV) challenge. | Front Genet | 2023 | 36873940 | PubTator, text mining | PubMed |
| Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies. | Am J Clin Oncol | 2023 | 36867653 | PubTator, text mining | PubMed |
| Remodeling oncogenic transcriptomes by small molecules targeting NONO. | Nat Chem Biol | 2023 | 36864190 | PubTator, text mining | PubMed |
| Drug Discovery Perspectives of Antisense Oligonucleotides. | Biomol Ther (Seoul) | 2023 | 36859811 | PubTator, text mining | PubMed |
| Selection and Evaluation of mRNA and miRNA Reference Genes for Expression Studies (qPCR) in Archived Formalin-Fixed and Paraffin-Embedded (FFPE) Colon Samples of DSS-Induced Colitis Mouse Model. | Biology (Basel) | 2023 | 36829468 | PubTator, text mining | PubMed |
| Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma. | Front Oncol | 2023 | 36816933 | PubTator, text mining | PubMed |
| Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature. | Front Oncol | 2023 | 36816927 | PubTator, text mining | PubMed |
| A computational map of the human-SARS-CoV-2 protein-RNA interactome predicted at single-nucleotide resolution. | NAR Genom Bioinform | 2023 | 36814457 | PubTator, text mining | PubMed |
| Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19. | Comput Biol Med | 2023 | 36805221 | PubTator, text mining | PubMed |
| LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma. | J Chemother | 2023 | 36797828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/papers?page=14